Trial · NCT02674464
Outcomes27
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 20 of 27
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Number of Participants With Controlled Blood Pressure | 12 months | We received BP data on 750 patients in the SCP arm and on 754 patients in the CC/SC arm from EMR's. | Participants | COUNT_OF_PARTICIPANTS |
| PRIMARY | Patient Activation Measure (PAM-13) | Baseline, 12 months | 790 patients in the SCP arm completed the follow-up survey at 12-months, but 1 patient did not complete the PAM-13 (primary patient-reported outcome) questions in the survey resulting in 789 patients in the sample. 733 patients in the CC/SC arm competed the follow-up survey at 12-months, but 2 patients did not complete the PAM-13 (primary patient-reported outcome) questions in the survey resulting in 731 patients in the sample. | score on a scale | LEAST_SQUARES_MEAN |
| SECONDARY | Mean Systolic Blood Pressure | Baseline, 12 months | We received BP data on 750 patients in the SCP arm and on 754 patients in the CC/SC arm from EMR's. | mm Hg | LEAST_SQUARES_MEAN |
| SECONDARY | Mean Diastolic Blood Pressure | Baseline, 12 months | We received BP data on 750 patients in the SCP arm and on 754 patients in the CC/SC arm from EMR's. | mm Hg | LEAST_SQUARES_MEAN |
| SECONDARY | Change in Global Framingham Risk Score | Baseline, 12, 24 months | |||
| SECONDARY | Change in Mean Total Cholesterol (mg/dL) | Baseline, 12, 24 months | |||
| SECONDARY | Change in Mean LDL-C (mg/dL) | Baseline, 12, 24 months | |||
| SECONDARY | Change in Mean HDL (mg/dL) | Baseline, 12, 24 months | |||
| SECONDARY | % With Controlled Total Cholesterol | Baseline | |||
| SECONDARY | % With Controlled Total Cholesterol | 12 months | |||
| SECONDARY | % With Controlled Total Cholesterol | 24 months | |||
| SECONDARY | Change in Mean Glycosylated Hemoglobin (Hemoglobin A1c) | Baseline, 12, 24 months | |||
| SECONDARY | % With Hemoglobin A1c< 7.0 | Baseline | |||
| SECONDARY | % With Hemoglobin A1c< 7.0 | 12 months | |||
| SECONDARY | % With Hemoglobin A1c< 7.0 | 24 months | |||
| SECONDARY | Change in Patient Assessment of Care for Chronic Conditions (PACIC-Plus) | Baseline, 12, 24 months | |||
| SECONDARY | % With BP <140/90 mmHg | 24 months | |||
| SECONDARY | % With BP <130/80 mmHg | 12 months | |||
| SECONDARY | % With BP <130/80 mmHg | 24 months | |||
| SECONDARY | % With BP <120/80 mmHg | 12 months |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02674464/outcomes